Mechanism of Action of Farxiga (Dapagliflozin)
Introduction Dapagliflozin (trade name Farxiga) is a sodium–glucose co‑transporter 2 (SGLT2) inhibitor used in type 2 diabetes mellitus (T2DM) and … Read more
Introduction Dapagliflozin (trade name Farxiga) is a sodium–glucose co‑transporter 2 (SGLT2) inhibitor used in type 2 diabetes mellitus (T2DM) and … Read more
Introduction Semaglutide (Ozempic for diabetes; Wegovy for obesity) is a GLP‑1 receptor agonist used for type 2 diabetes mellitus … Read more
Introduction Bupropion is an atypical antidepressant primarily used to treat major depressive disorder, seasonal affective disorder, and as … Read more
Introduction Lokelma is an oral, non-absorbed potassium binder used to treat hyperkalemia. It works by selectively trapping potassium … Read more
Introduction Finerenone is a nonsteroidal, selective mineralocorticoid receptor antagonist (MRA) approved for reducing the risk of cardiovascular and … Read more
Introduction Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for obesity, is a dual GIP/GLP‑1 receptor … Read more
Introduction Entresto is a combination drug containing sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker … Read more
Introduction Octreotide is a synthetic somatostatin analog used to treat acromegaly, carcinoid syndrome, VIPoma, and control of panhormonal … Read more
Introduction Adenosine is an endogenous purine nucleoside used intravenously for the acute termination of paroxysmal supraventricular tachycardia (PSVT). … Read more
Introduction Acetazolamide is a carbonic anhydrase inhibitor with diuretic, antiglaucoma, anticonvulsant, and altitude sickness applications. It reduces bicarbonate … Read more